scholarly journals Phytochemical Screening of Halophytic Plant Heliotropium curassavicum L.

Author(s):  
Rachana Suthar ◽  
Hiteshkumar A. Solanki

According to the World Health Organization, plants are a source of compounds that have the ability to combat disease, antimicrobial, antiviral and antifungal activities. The most important of these bioactive constituents of plants are alkaloids, tannins, flavonoids and phenolic compounds. Halophytes are salt tolerant plants. They contain high amount of secondary metabolites or phytoconstituents. Correlation between the phytoconstituents and the bioactivity of plant is desirable to know for the synthesis of compounds with specific activities to treat various health ailments and chronic diseases as well. The study of the halophytic plant for the preliminary screening of different phytoconstituents is important. Here, I have done preliminary phytochemical screening of Halophytic plant Heliotropium Curassavicum L.

2016 ◽  
Vol 5 (1) ◽  
pp. 25
Author(s):  
Eva Salas Olivet ◽  
José González ◽  
Armando Cuéllar ◽  
Max Monan ◽  
Yuliamny Adames ◽  
...  

Towards authentication and quality assurance of medicinal plants, pharmacognostic, physicochemical, phytochemical and preliminary antibacterial studies of the leaves of Ocimum tenuiflorum Linn, were carried out. The macroscopic evaluation revealed characters that are of diagnostic value and useful in authentication of the plant. The physicochemical analyses reveals values for moisture content (12.46 %), alcohol extractive (0.5 %), and total ash (11.5 %) which are within the World Health Organization (WHO) standards for crude drug from medicinal plants, except the last one. Phytochemical screening for secondary metabolites revealed the presence of fats, alkaloids, saponins, triterpens/steroids, reductants sugars, flavonoids, free aminoacids or amines, quinones, anthocyanins and mucilage, and phenolic compounds, while resins and balsams, coumarins and tannins were absent. Information obtained from these studies can be used as markers in the identification and standardization of this plant as a herbal remedy and also towards monograph development on the plant.


2021 ◽  
Vol 2 (3) ◽  
pp. 295-301
Author(s):  
Ivana Stašević-Karličić

In order to preserve and improve public health, guided by the recommendations of the World Health Organization (WHO), the Clinic for Mental Disorders Dr Laza Lazarević, in cooperation with the Ministry of Health of the Republic of Serbia, developed a strategy for mental healthcare during the COVID-19 pandemic. This paper briefly presents some specific activities that the Clinic for Mental Disorders Dr Laza Lazarević has carried out during the current COVID-19 pandemic.


2017 ◽  
Vol 79 (07) ◽  
pp. 526-527

Coenen M et al. [Recommendation for the collection and analysis of data on participation and disability from the perspective of the World Health Organization]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 59: 1060–1067 Um eine gleichberechtigte Teilhabe an der Gesellschaft von Menschen mit Behinderung zu ermöglichen, werden zunächst Daten zu vorhandenen Einschränkungen gebraucht. Erst wenn diese detailliert erhoben wurden, können Konzepte zur Beseitigung von Problemen entwickelt werden. Ein standardisiertes Erhebungsinstrument für alle Aspekte der Funktionsfähigkeit fehlte jedoch bisher.


2020 ◽  
pp. 276-289
Author(s):  
Mobina Fathi ◽  
Kimia Vakili ◽  
Niloofar Deravi

Around the end of December 2019, a new beta-coronavirus from Wuhan City, Hubei Province, China began to spread rapidly. The new virus, called SARS-CoV-2, which could be transmitted through respiratory droplets, had a range of mild to severe symptoms, from simple cold in some cases to death in others. The disease caused by SARS-CoV-2 was named COVID-19 by WHO and has so far killed more people than SARS and MERS. Following the widespread global outbreak of COVID-19, with more than 132758 confirmed cases and 4955 deaths worldwide, the World Health Organization declared COVID-19 a pandemic disease in January 2020. Earlier studies on viral pneumonia epidemics has shown that pregnant women are at greater risk than others. During pregnancy, the pregnant woman is more prone to infectious diseases. Research on both SARS-CoV and MERS-CoV, which are pathologically similar to SARS-CoV-2, has shown that being infected with these viruses during pregnancy increases the risk of maternal death, stillbirth, intrauterine growth retardation and, preterm delivery. With the exponential increase in cases of COVID-19 throughout the world, there is a need to understand the effects of SARS-CoV-2 on the health of pregnant women, through extrapolation of earlier studies that have been conducted on pregnant women infected with SARS-CoV, and MERS-CoV. There is an urgent need to understand the chance of vertical transmission of SARS-CoV-2 from mother to fetus and the possibility of the virus crossing the placental barrier. Additionally, since some viral diseases and antiviral drugs may have a negative impact on the mother and fetus, in which case, pregnant women need special attention for the prevention, diagnosis, and treatment of COVID-19.


Author(s):  
Zen Ahmad

Corona Virus Disease (Covid-19) is a contagious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was discovered in December 2019 in China. This disease can cause clinical manifestations in the airway, lung and systemic. The World Health Organization (WHO) representative of China reported a pneumonia case with unknown etiology in Wuhan City, Hubei Province, China on December 31, 2019. The cause was identified as a new type of coronavirus on January 7, 2020 with an estimated source of the virus from traditional markets (seafood market). ) Wuhan city


Sign in / Sign up

Export Citation Format

Share Document